U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
100021100021Trifecta Durability StudyActive, not recruitingNo Results AvailableAortic Valve DisorderDevice: Implantation of the Trifecta Valvehttps://ClinicalTrials.gov/show/NCT01256710
100022100022The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis PigmentosaCompletedNo Results AvailableRetinitis PigmentosaDietary Supplement: Alga Dunaliella Bardawil|Dietary Supplement: Alga Dunaliella Bardawill|Other: Sugar pillhttps://ClinicalTrials.gov/show/NCT01256697
100023100023DHEA Against Vaginal Atrophy - 3-Month Efficacy StudyCompletedNo Results AvailableVaginal AtrophyDrug: Placebo|Drug: DHEA|Drug: DHEAhttps://ClinicalTrials.gov/show/NCT01256684
100024100024DHEA Against Vaginal Atrophy - Safety Study of 12 MonthsCompletedNo Results AvailableVaginal AtrophyDrug: DHEAhttps://ClinicalTrials.gov/show/NCT01256671
100025100025A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)CompletedHas ResultsMalariaDrug: COA566https://ClinicalTrials.gov/show/NCT01256658
100026100026Transfusion Strategies in Weaning PatientsRecruitingNo Results AvailableWeaning PatientsOther: blood transfusionhttps://ClinicalTrials.gov/show/NCT01256645
100027100027Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab TherapyCompletedNo Results AvailableChoroidal NeovascularizationDrug: Ranibizumabhttps://ClinicalTrials.gov/show/NCT01256632
100028100028Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's HealthRecruitingNo Results AvailableWomen With PMSDrug: Marvelonhttps://ClinicalTrials.gov/show/NCT01256619
100029100029Prenatal Test for Fetal Aneuploidy DetectionCompletedNo Results AvailableAneuploidy|Trisomy 21https://ClinicalTrials.gov/show/NCT01256606
100030100030Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)Active, not recruitingNo Results AvailableNeuralgiaDrug: Pregabalin (Lyrica) capsulehttps://ClinicalTrials.gov/show/NCT01256593
100031100031Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMDWithdrawnNo Results AvailableChoroidal Neovascularization|Myopia|Punctate Inner Choroidopathy (PIC)|Multifocal Choroiditis|Ocular Histoplasmosis Syndrome|Central Serous Chorioretinopathy (CSC)|Angioid Streaks|Trauma, or Hereditary Eye DiseasesDrug: Bevacizumab (Avastin; Genentech, Inc.)|Drug: Bevacizumab, Dexamethasone, Verteporfin Photodynamic Therapyhttps://ClinicalTrials.gov/show/NCT01256580
100032100032A Study of Ramucirumab (IMC-1121B) in Participants With Breast CancerCompletedHas ResultsBreast Cancer|Metastatic Breast CancerBiological: Ramucirumab|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT01256567
100033100033Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord CompressionActive, not recruitingNo Results AvailableMetastatic Epidural Spinal Cord CompressionProcedure: Stereotactic Radiosurgery (SSRS)|Behavioral: Questionnaireshttps://ClinicalTrials.gov/show/NCT01256554
100034100034Kristalose as Bowel Evacuant Prior to ColonoscopyCompletedNo Results AvailableBowel Evacuant Prior to ColonoscopyDrug: Kristalosehttps://ClinicalTrials.gov/show/NCT01256541
100035100035Delayed-Delayed Breast ReconstructionCompletedNo Results AvailableBreast CancerProcedure: Delayed Breast Reconstructionhttps://ClinicalTrials.gov/show/NCT01256528
100036100036Health Management Training to Enhance Influenza Vaccine ImmunogenicityCompletedNo Results AvailableNo ConditionsBehavioral: Health Education|Behavioral: Health Education Traininghttps://ClinicalTrials.gov/show/NCT01256515
100037100037The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction SurgeryCompletedHas ResultsBreast ReconstructionDevice: SERI® Surgical Scaffoldhttps://ClinicalTrials.gov/show/NCT01256502
100038100038Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)RecruitingNo Results AvailableStevens-Johnson Syndrome|Corneal BlindnessDrug: Infliximabhttps://ClinicalTrials.gov/show/NCT01256489
100039100039Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed DyslipidemiaCompletedHas ResultsPrimary Dyslipidemia|Mixed DyslipidemiaDrug: pitavastatin|Drug: pravastatinhttps://ClinicalTrials.gov/show/NCT01256476
100040100040HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment SettingsActive, not recruitingNo Results AvailableHIVBehavioral: HIV prevention interventionhttps://ClinicalTrials.gov/show/NCT01256463
100041100041Efficacy and Safety Study of BEMA Buprenorphine in Subjects With Low Back PainCompletedNo Results AvailablePain|Low Back PainDrug: BEMA Buprenorphine|Drug: BEMA Placebohttps://ClinicalTrials.gov/show/NCT01256450
100042100042Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream Lotion, for EGFR'I Induced Acneiform RashRecruitingNo Results AvailableAcneiform RashDrug: Threolone ointment|Drug: ointment Synthomycine|Drug: Aqua cream lotionhttps://ClinicalTrials.gov/show/NCT01256437
100043100043Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical NeoplasiaCompletedHas ResultsCervical Intraepithelial NeoplasiaDrug: HAL 5% with illumination|Drug: HAL 1% with illumination|Drug: HAL 0.2% with illumination|Drug: Placebo ointment without illuminationhttps://ClinicalTrials.gov/show/NCT01256424
100044100044A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential HypertensionCompletedNo Results AvailableEssential HypertensionDrug: LCZ696https://ClinicalTrials.gov/show/NCT01256411
100045100045Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaActive, not recruitingNo Results AvailableAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1|Untreated Adult Acute Lymphoblastic LeukemiaBiological: Alemtuzumab|Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Procedure: Autologous Hematopoietic Stem Cell Transplantation|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dasatinib|Drug: Daunorubicin Hydrochloride|Drug: Dexamethasone|Drug: Etoposide Phosphate|Biological: Filgrastim|Drug: Fludarabine Phosphate|Procedure: In Vitro-Treated Peripheral Blood Stem Cell Transplantation|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Melphalan|Drug: Mercaptopurine|Drug: Methotrexate|Biological: Pegfilgrastim|Other: Pharmacological Study|Drug: Tacrolimus|Drug: Vincristine Sulfatehttps://ClinicalTrials.gov/show/NCT01256398
100046100046Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous TherapyActive, not recruitingNo Results AvailableRecurrent Hypopharyngeal Squamous Cell Carcinoma|Recurrent Laryngeal Squamous Cell Carcinoma|Recurrent Laryngeal Verrucous Carcinoma|Recurrent Lip and Oral Cavity Squamous Cell Carcinoma|Recurrent Metastatic Squamous Cell Carcinoma in the Neck With OccultBiological: Cetuximab|Other: Laboratory Biomarker Analysis|Drug: Temsirolimushttps://ClinicalTrials.gov/show/NCT01256385
100047100047An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac SurgeryCompletedNo Results AvailableCardiac Surgery|Coronary Artery Bypass|Aortic Aneurysm|Valve Surgery|Kidney DiseasesDrug: AP214|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01256372
100048100048Docetaxel With or Without AZD6244 in MelanomaActive, not recruitingNo Results AvailableMelanomaDrug: Docetaxel and AZD6244|Drug: Docetaxel and placebohttps://ClinicalTrials.gov/show/NCT01256359
100049100049Electrocardiography Versus Pulse Oximetry for Newborn Heart Rate DeterminationWithdrawnNo Results AvailablePrematurityDevice: Apparatuseshttps://ClinicalTrials.gov/show/NCT01256346
100050100050Optimization of Arterial Oxygen Transport by Positive End-expiratory Pressure Variation in Acute Respiratory Distress SyndromeCompletedNo Results AvailableRespiratory Distress Syndrome, Adulthttps://ClinicalTrials.gov/show/NCT01256333

* Görseller ve İçerik tekif hakkına sahip olabilir